Open-Label, Post-Marketing Study to Evaluate the Performance…
Established
12
Citations0
Refs2019
Year
Search Works
Work Details
- PMID https://pubmed.ncbi.nlm.nih.gov/30681803
- OpenAlex ID W3004132010
- Type Article
- Language EN
- Published 01 Jan 2019
- Volume 18 (1)
- Pages 86–91
- Source PubMed
- Publisher National Institutes of Health
- FWCI 1.52
- Added 07 Feb 2020
- Updated 16 Oct 2026
External Links
MENU
0
Open-Label, Post-Marketing Study to Evaluate the Performance and Safety of Calcium Hydroxylapatite With Integral Lidocaine to Correct Facial Volume Loss
Article 2019 EN
Background: Calcium hydroxylapatite (CaHA, Radiesse®) with integral 0.3% lidocaine (CaHA(+)) has recently been approved for use in aesthetic medicine. This study assessed the performance of CaHA(+) in subjects undergoing treatment for facial volume loss and evaluated subject and physician satisfaction. Methods: In a prospective, open-label, post-marketing study, 25 women seeking treatment for age-…
12
Citations
0
References
1
Authors
1.52
FWCI
Citations by Year
Last 6 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
1 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Gabriele F. Muti Corresponding | — | — |
Related Works
10Data: OpenAlex